LONGO, Filomena
 Distribuzione geografica
Continente #
NA - Nord America 785
EU - Europa 361
AS - Asia 164
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.319
Nazione #
US - Stati Uniti d'America 781
IT - Italia 97
CN - Cina 87
IE - Irlanda 66
SE - Svezia 56
SG - Singapore 32
FR - Francia 29
DE - Germania 27
DK - Danimarca 24
UA - Ucraina 17
VN - Vietnam 17
AT - Austria 14
IN - India 12
FI - Finlandia 9
BE - Belgio 8
GB - Regno Unito 6
CA - Canada 4
HK - Hong Kong 3
KE - Kenya 3
KR - Corea 3
UZ - Uzbekistan 3
A1 - Anonimo 2
CZ - Repubblica Ceca 2
PK - Pakistan 2
PL - Polonia 2
AU - Australia 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
SN - Senegal 1
TH - Thailandia 1
Totale 1.319
Città #
Chandler 155
Ann Arbor 82
Dublin 66
Beijing 55
Torino 44
Fairfield 43
Nyköping 32
Singapore 24
Villeurbanne 24
Ashburn 23
Houston 23
Medford 22
Cambridge 21
Wilmington 21
Dearborn 19
Princeton 18
Jacksonville 17
Seattle 14
Vienna 14
Woodbridge 13
Dong Ket 11
Boston 8
Brussels 8
Fremont 7
Turin 6
Boardman 5
Jinan 5
New York 5
Hefei 4
Los Angeles 4
Norwalk 4
Pisa 4
Pune 4
Redwood City 4
Toronto 4
Brecon 3
Esslingen am Neckar 3
Frankfurt am Main 3
Guangzhou 3
Hangzhou 3
Rome 3
Santa Clara 3
Upper Marlboro 3
Brno 2
Caronno Pertusella 2
Central District 2
Chennai 2
Fall River 2
Genoa 2
Helsinki 2
Munich 2
Nairobi 2
Nanchang 2
Salt Lake City 2
San Mateo 2
San Mauro Torinese 2
Shanghai 2
Silver Spring 2
Stockholm 2
Warsaw 2
Washington 2
West Jordan 2
Wuhan 2
Xiamen 2
Xian 2
Arbil 1
Auckland 1
Berlin 1
Bologna 1
Buffalo 1
Campobasso 1
Canberra 1
Changchun 1
Chengdu 1
Coralville 1
Duncan 1
Falkenstein 1
Gokasho 1
Hong Kong 1
Islamabad 1
Jakarta 1
Leiden 1
London 1
Manchester 1
Milan 1
Moscow 1
Nanjing 1
Nanning 1
Peshawar 1
Philadelphia 1
Pofi 1
Rivalta Di Torino 1
San Diego 1
San Francisco 1
Sassari 1
Seoul 1
Springfield 1
Syosset 1
Tampa 1
Tappahannock 1
Totale 916
Nome #
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 160
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 117
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with b-thalassemia 115
Plasma and red blood cell pufas in home parenteral nutrition paediatric patients—effects of lipid emulsions 111
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 93
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 88
Exercise Stress Echocardiography with Tissue Doppler Imaging (TDI) Detects Early Systolic Dysfunction in Beta-Thalassemia Major Patients without Cardiac Iron Overload 77
Clinical relevance of deferasirox trough levels in β-thalassemia patients 74
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 72
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring 63
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 62
Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children 57
Epigenetic Therapy for Friedreich’s Ataxia: A Phase I Clinical Trial 54
Worsening of myocardial performance index in beta-thalassemia patients despite permanently normal iron load at MRI: A simple and cheap index reflecting cardiovascular involvement? 52
Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy? 47
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 47
Liver stiffness assessed by transient elastography in patients with β thalassaemia major 44
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 27
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 16
Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Comparison of Deferasirox Formulations for Treatment Tailoring 7
Totale 1.383
Categoria #
all - tutte 4.751
article - articoli 0
book - libri 0
conference - conferenze 512
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 14 6 28 17 7 5 21 17 14
2020/2021203 9 7 11 4 12 3 53 6 17 13 25 43
2021/2022269 9 14 31 20 10 21 14 12 7 14 65 52
2022/2023389 36 42 13 39 33 91 18 32 39 15 21 10
2023/2024141 24 30 7 9 8 14 1 6 1 13 8 20
2024/202524 5 17 2 0 0 0 0 0 0 0 0 0
Totale 1.383